Remarkable advances in EDC systems you need to know with Zach Taft, MBA (Memorial Sloan Kettering Cancer Center) #EDCSystems #MedicalAdvances #Research #OncoDaily #Oncology #CancerResearch
Great article, Zach Taft, MBA 👏.
Skip to main content
Remarkable advances in EDC systems you need to know with Zach Taft, MBA (Memorial Sloan Kettering Cancer Center) #EDCSystems #MedicalAdvances #Research #OncoDaily #Oncology #CancerResearch
Great article, Zach Taft, MBA 👏.
To view or add a comment, sign in
🗣 We are glad to announce that our latest paper named “A Vision for Democratizing Next-Generation Oncology Clinical Trials” has just been published at the American Association for Cancer Research Congress in #SanDiego! 📝 This work has been a collaboration of our Executive Director Denis Horgan, Ph.D, Ishwaria Subbiah, MD, MS, FASCO. & Vivek Subbiah, MD. If you want to learn more about how leveraging technology, collaboration, and streamlined processes accelerates the translation of scientific discoveries into effective treatments, fostering a dynamic ecosystem dedicated to efficient and ethical execution you can read the full article here: 🖇 https://lnkd.in/dXwMPETM 🤝 We must tap into collaboration, innovation, and community engagement to translate research into accessible treatments to drive precision medicine trials forward for a healthier future. #AACR #CancerResearch #Innovation #TogetherAgainstCancer #Oncology #CancerAwareness #FightCancer #ResearchMatters #CancerTreatment #PrecisionMedicine #CancerSurvivor #ClinicalTrials #HopeForACure
To view or add a comment, sign in
Incredible scientists, physicians and experts in clinical research. Great teams collaborating and enhancing the knowledge in oncology. #ESMO2024 #Oncology #ClinicalTrials #CancerResearch #Innovation #MedicalAdvances #Collaboration #ClinicalTrials #ClinicalResearch
Day 3 at ESMO2024 - Advancing Oncology Together!! Three days into ESMO - European Society for Medical Oncology Congress, and the momentum keeps building! One key takeaway has been the incredible 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗶𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀. The advancements shared on trial results, innovative designs, and patient-focused approaches highlight how these efforts drive the future of cancer treatment. It's inspiring to see how clinical research translates into 𝗿𝗲𝗮𝗹 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 and pushes the boundaries of what's possible in oncology. With just one day left, we’re excited for the final insights and connections! Feel free to stop by 𝗕𝗼𝗼𝘁𝗵 𝟱𝟭𝟳 — our team will be happy to welcome you! #ESMO2024 #Oncology #ClinicalTrials #CancerResearch #Innovation #MedicalAdvances #Collaboration #ClinicalTrials #ClinicalResearch
To view or add a comment, sign in
ESMO 2024 wasn't just a conference – it was a launchpad for continued scientific advances in Oncology. At HCG, we're all about accelerating science's impact, and we're excited to share our latest analysis: "Advancing Oncology Partnerships: Insights from the Year's Premier Oncology Congresses." We've distilled ESMO 2024's game-changing highlights and compared them with ASCO, offering you a sharp view of this year's most impactful developments. Want to know how these scientific milestones are reshaping cancer care and amplifying progress? Dive into our thought leadership piece! Looking to learn more? Looking to drive impact in your medical communications? Visit us at www.hcg-int.com #medcomms #medcommsimpact #ESMO2024 #ESMO2024 #oncology #ASCO2024
To view or add a comment, sign in
🎙️ Tune in to our Advancing Precision Oncology Podcast! This 3-part series will explore how biomarkers and advanced testing capabilities are expanding patient access to precision oncology and improving health outcomes for cancer patients. Delve into the rapidly evolving landscape of biomarker testing, the benefits of integrating multi-data sources and the challenges and opportunities that lie ahead. 🔬💊 Listen to Part 1 with Dr. Gwyn Bebb and Wyatt Gotbetter: https://lnkd.in/e4-kBAmF #ParexelBiotech #Oncology #Biomarkers #NovelInsights
To view or add a comment, sign in
🎙️ Tune in to our Advancing Precision Oncology Podcast! This 3-part series will explore how biomarkers and advanced testing capabilities are expanding patient access to precision oncology and improving health outcomes for cancer patients. Delve into the rapidly evolving landscape of biomarker testing, the benefits of integrating multi-data sources and the challenges and opportunities that lie ahead. 🔬💊 Listen to Part 1 with Dr. Gwyn Bebb and Wyatt Gotbetter: https://lnkd.in/eGs_hjRP #ParexelBiotech #Oncology #Biomarkers #NovelInsights
To view or add a comment, sign in
🎙️ Tune in to our Advancing Precision Oncology Podcast! This 3-part series will explore how biomarkers and advanced testing capabilities are expanding patient access to precision oncology and improving health outcomes for cancer patients. Delve into the rapidly evolving landscape of biomarker testing, the benefits of integrating multi-data sources and the challenges and opportunities that lie ahead. 🔬💊 Listen to Part 1 with Dr. Gwyn Bebb and Wyatt Gotbetter: https://lnkd.in/eHnaybNk #ParexelBiotech #Oncology #Biomarkers #NovelInsights
To view or add a comment, sign in
Clinical trial trends play a pivotal role in shaping the future of cancer treatment. The dynamics of oncology clinical trials are undergoing significant transformations, driven by emerging technologies, evolving regulatory landscapes, and shifting patient needs. Read more in this article: https://bit.ly/43V6l5D #ClinicalTrialsArena #CROs #Oncology #PatientNeeds
To view or add a comment, sign in
Ready to revolutionize your oncology clinical trials? Join our exclusive webinar to discover cutting-edge strategies for optimizing data flow in early-phase trials. We'll dive deep into overcoming bottlenecks, enhancing patient safety, and streamlining trial processes. Learn how improved cohort management, site support, and EDC system selection can make a significant impact. This is your chance to transform your clinical trials and drive groundbreaking innovations in cancer treatment. Don't miss out—register today! https://bit.ly/3XfLfNU #Oncology #ClinicalTrials #DataFlow #Innovation
To view or add a comment, sign in
🎙️ Tune in to our Advancing Precision Oncology Podcast! This 3-part series will explore how biomarkers and advanced testing capabilities are expanding patient access to precision oncology and improving health outcomes for cancer patients. Delve into the rapidly evolving landscape of biomarker testing, the benefits of integrating multi-data sources and the challenges and opportunities that lie ahead. 🔬💊 Listen to Part 1 with Dr. Gwyn Bebb and Wyatt Gotbetter: https://lnkd.in/eBq-jix6 #ParexelBiotech #Oncology #Biomarkers #NovelInsights
To view or add a comment, sign in
🎙️ Tune in to our Advancing Precision Oncology Podcast! This 3-part series will explore how biomarkers and advanced testing capabilities are expanding patient access to precision oncology and improving health outcomes for cancer patients. Delve into the rapidly evolving landscape of biomarker testing, the benefits of integrating multi-data sources and the challenges and opportunities that lie ahead. 🔬💊 Listen to Part 1 with Dr. Gwyn Bebb and Wyatt Gotbetter: https://lnkd.in/gdC7SxDf #ParexelBiotech #Oncology #Biomarkers #NovelInsights
To view or add a comment, sign in
30,291 followers
Create your free account or sign in to continue your search
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Service Chief & Attending Physician Rad Onc, Memorial Sloan Kettering; Steering Committee, Clinical Research Innovation Consortium (CRIC); Co-Founder and Senior Advisor, Global Medical Affairs, AI MINDSystems Foundation
4moAs a clinical trialist with over a decade worth of experience across the spectrum of trial activity, I can't overstate what a game changer this could be. Great work Zach Taft, MBA and teams at IgniteData and ZS.